Paper Details

  1. Home
  2. Paper Details

A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.

Author: KayS R, SinghM M

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Haloperidol was generally more effective than chlorpromazine in treating schizophrenic patients. Haloperidol was faster-acting and showed greater improvement in social, emotional, and cognitive areas. Chlorpromazine resulted in less dysphoria compared to haloperidol. Benztropine was found to diminish therapeutic response to both neuroleptics, with haloperidol being less susceptible to this effect.
Paper Details　
Original Abstract of the Article :
In a double-blind, cross-over study, the comparative therapeutic effects of 6-week courses of two prototypic neuroleptics--haloperidol and chlorpromazine--and the reversal of those effects with benztropine were investigated in a group of 18 schizophrenics. Periodic measurements were made for 32 dime...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF00421012

データ提供：米国国立医学図書館（NLM）

Haloperidol vs. Chlorpromazine: A Showdown in Schizophrenia

This study takes us on a journey into the complex world of schizophrenia, comparing the therapeutic effects of two classic neuroleptic drugs, haloperidol and chlorpromazine. Imagine two different desert nomads, each with their unique skills and strengths. The researchers meticulously documented the effects of these medications on a range of psychiatric and physiological parameters, including social participation, attention span, and neurological side effects.

Haloperidol Emerges as the More Effective Contender

The study revealed that haloperidol generally outperformed chlorpromazine in terms of therapeutic efficacy, particularly in areas like social and emotional responsiveness, communication, and cognitive function. While chlorpromazine might have been slightly better at reducing dysphoria, haloperidol showed a more rapid onset of action.

Understanding the Role of Anticholinergic Activity

The study also explored the role of anticholinergic activity in the effectiveness of these medications. The findings suggest that anticholinergic properties, while potentially contributing to the therapeutic effects, may also impede the overall potency of certain neuroleptics, like chlorpromazine. This complex interplay highlights the need for careful consideration of the individual patient's needs and potential side effects.

Dr.Camel's Conclusion

This research offers a valuable comparison between two neuroleptic drugs used in the management of schizophrenia. It reveals the nuanced differences in their therapeutic efficacy and sheds light on the potentially complex interplay between anticholinergic activity and drug potency. This study acts as a compass, guiding clinicians in their quest to find the most effective treatment options for individuals battling schizophrenia.

Date :
  1. Date Completed 1976-01-14
  2. Date Revised 2020-02-25
Further Info :

Pubmed ID

1103205

DOI: Digital Object Identifier

10.1007/BF00421012

Related Literature

Article Analysis
・Effects of benztropine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.